iBio, Inc. Common Stock (IBIO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $3.07
• Market Cap: $99.14M
• EPS: $-1.00
• 52-Week High: $6.89
• 52-Week Low: $0.56

Market Sentiment

iBio, Inc. Common Stock currently has a Bullish sentiment score of 0.34.

About iBio, Inc. Common Stock

iBio, Inc. is a pioneering biotechnology firm specializing in plant-based biopharmaceutical production, headquartered in New York. The company offers contract development and manufacturing services for biologics, focusing on vaccines and therapeutics, thereby serving as a vital partner for organizations in the United States and internationally. With its proprietary technologies, iBio is dedicated to improving efficiency and scalability in the biologics manufacturing process, addressing the in...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for iBio, Inc. Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IBIO pay dividends?

iBio, Inc. Common Stock (IBIO) does not currently pay a regular dividend.

What is IBIO's market cap?

iBio, Inc. Common Stock (IBIO) has a market capitalization of $99.14M with a current stock price of $3.07.